Skip to main content
PMC home page
Journal of Clinical Pathology logoLink to Journal of Clinical Pathology
. 1994 Sep;47(9):839–842. doi: 10.1136/jcp.47.9.839

Influence of nifedipine on interstitial fibrosis in renal transplant allografts treated with cyclosporin A.

T A McCulloch 1, S J Harper 1, P K Donnelly 1, J Moorhouse 1, P R Bell 1, J Walls 1, J Feehally 1, P N Furness 1
PMCID: PMC494942  PMID: 7962654

Abstract

AIMS--To compare the degree of interstitial fibrosis in renal transplant biopsy specimens from immunosuppressed patients using conventional doses of cyclosporin with and without calcium channel blockade with a combination of low dose cyclosporin and azathioprine; to correlate the degree of interstitial fibrosis with the glomerular filtration rate. METHODS--A single blind histomorphometric assessment was done of cortical interstitial volume fraction from biopsy specimens taken intraoperatively and at one, six, and 12 months after transplantation from three prospectively randomised groups of patients: (A) conventional dose cyclosporin; (B) conventional dose cyclosporin plus nifedipine; (C) low dose cyclosporin plus azathioprine. RESULTS--Interstitial volume increased with time in all groups. No differences in interstitial volume were present at operation or at one month, but at six months interstitial volume was significantly less in group B than group A (p < 0.001) or group C (p < 0.05). More grafts failed in group A than group B leaving only small numbers for comparison at 12 months. At 12 months the differences persisted but did not reach significance. These results strongly reflected the clinical findings, where glomerular filtration rate was significantly lower in group A than groups B or C at six and 12 months; no differences in glomerular filtration rate were found at one month. In a direct comparison glomerular filtration rate showed a significant negative correlation with interstitial volume fraction. CONCLUSIONS--These findings suggest that calcium channel blockade with nifedipine slows the development of interstitial fibrosis in renal transplant recipients treated with cyclosporin. When clinical data are considered, it is suggested that calcium channel blockade may have a mitigating effect on the long term nephrotoxic effects of cyclosporin and should be considered as adjunctive treatment in patients requiring this immunosuppressant following renal transplantation.

Full text

PDF
842

Images in this article

840Image
on p.840

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bignardi L., Neild G. H., Hartley R. B., Taube D. H., Cameron J. S., Rudge C. J., Williams D. G., Ogg C. S. Histopathological changes in cyclosporin-treated renal allografts biopsied at one and twelve months. Nephrol Dial Transplant. 1987;2(5):366–370. [PubMed] [Google Scholar]
  2. Cheung J. Y., Bonventre J. V., Malis C. D., Leaf A. Calcium and ischemic injury. N Engl J Med. 1986 Jun 26;314(26):1670–1676. doi: 10.1056/NEJM198606263142604. [DOI] [PubMed] [Google Scholar]
  3. Dieterle A., Gratwohl A., Nizze H., Huser B., Mihatsch M. J., Thiel G., Tichelli A., Signer E., Nissen C., Speck B. Chronic cyclosporine-associated nephrotoxicity in bone marrow transplant patients. Transplantation. 1990 Jun;49(6):1093–1100. doi: 10.1097/00007890-199006000-00013. [DOI] [PubMed] [Google Scholar]
  4. Gladue R. P., Newborg M. F. The protective effects of the thromboxane synthetase inhibitor Dazmegrel on nephrotoxicity in cyclosporine-treated rats. Transplantation. 1991 Nov;52(5):837–841. doi: 10.1097/00007890-199111000-00016. [DOI] [PubMed] [Google Scholar]
  5. Harper S. J., Moorhouse J., Veitch P. S., Horsburgh T., Walls J., Bell P. R., Donnelly P. K., Feehally J. Nifedipine improves immediate, and 6- and 12-month graft function in cyclosporin A (CyA) treated renal allograft recipients. Transpl Int. 1992;5 (Suppl 1):S69–S72. doi: 10.1007/978-3-642-77423-2_23. [DOI] [PubMed] [Google Scholar]
  6. McNally P. G., Baker F., Mistry N., Walls J., Feehally J. Effect of nifedipine on renal haemodynamics in an animal model of cyclosporin A nephrotoxicity. Clin Sci (Lond) 1990 Sep;79(3):259–266. doi: 10.1042/cs0790259. [DOI] [PubMed] [Google Scholar]
  7. McNally P. G., Walls J., Feehally J. The effect of nifedipine on renal function in normotensive cyclosporin-A-treated renal allograft recipients. Nephrol Dial Transplant. 1990;5(11):962–968. doi: 10.1093/ndt/5.11.962. [DOI] [PubMed] [Google Scholar]
  8. Myers B. D. Cyclosporine nephrotoxicity. Kidney Int. 1986 Dec;30(6):964–974. doi: 10.1038/ki.1986.280. [DOI] [PubMed] [Google Scholar]
  9. Myers B. D., Ross J., Newton L., Luetscher J., Perlroth M. Cyclosporine-associated chronic nephropathy. N Engl J Med. 1984 Sep 13;311(11):699–705. doi: 10.1056/NEJM198409133111103. [DOI] [PubMed] [Google Scholar]
  10. Neild G. H., Taube D. H., Hartley R. B., Bignardi L., Cameron J. S., Williams D. G., Ogg C. S., Rudge C. J. Morphological differentiation between rejection and cyclosporin nephrotoxicity in renal allografts. J Clin Pathol. 1986 Feb;39(2):152–159. doi: 10.1136/jcp.39.2.152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Palestine A. G., Austin H. A., 3rd, Balow J. E., Antonovych T. T., Sabnis S. G., Preuss H. G., Nussenblatt R. B. Renal histopathologic alterations in patients treated with cyclosporine for uveitis. N Engl J Med. 1986 May 15;314(20):1293–1298. doi: 10.1056/NEJM198605153142005. [DOI] [PubMed] [Google Scholar]
  12. Petric R., Freeman D., Wallace C., McDonald J., Stiller C., Keown P. Modulation of experimental cyclosporine nephrotoxicity by inhibition of thromboxane synthesis. Transplantation. 1990 Oct;50(4):558–563. doi: 10.1097/00007890-199010000-00005. [DOI] [PubMed] [Google Scholar]
  13. Ruiz P., Kolbeck P. C., Scroggs M. W., Sanfilippo F. Associations between cyclosporine therapy and interstitial fibrosis in renal allograft biopsies. Transplantation. 1988 Jan;45(1):91–95. doi: 10.1097/00007890-198801000-00021. [DOI] [PubMed] [Google Scholar]
  14. Santelli G., Hiesse C., Schovaert D., Fassi-Fihri S., Lantz O., Bensadoun H., Benoit G., Charpentier B., Martin E., Fries D. Pathology of two-year renal biopsies in cyclosporine and conventionally immunosuppressed renal transplants. Transplant Proc. 1989 Feb;21(1 Pt 2):1674–1676. [PubMed] [Google Scholar]
  15. Savoldi S., Scolari F., Sandrini S., Scaini P., Sacchi G., Tardanico R., Camerini C., Salerni B., Tonini G., De Nobili U. Cyclosporine chronic nephrotoxicity: histologic follow-up at 6 and 18 months after renal transplantation. Transplant Proc. 1988 Jun;20(3 Suppl 3):777–784. [PubMed] [Google Scholar]
  16. Schainuck L. I., Striker G. E., Cutler R. E., Benditt E. P. Structural-functional correlations in renal disease. II. The correlations. Hum Pathol. 1970 Dec;1(4):631–641. doi: 10.1016/s0046-8177(70)80061-2. [DOI] [PubMed] [Google Scholar]
  17. Svenson K., Bohman S. O., Hällgren R. Renal interstitial fibrosis and vascular changes. Occurrence in patients with autoimmune diseases treated with cyclosporine. Arch Intern Med. 1986 Oct;146(10):2007–2010. [PubMed] [Google Scholar]
  18. Wilczek H. E., Groth C. G., Bohman S. O. Effect of reduced cyclosporin dosage on long-term renal allograft histology. Transpl Int. 1992 May;5(2):65–70. doi: 10.1007/BF00339218. [DOI] [PubMed] [Google Scholar]
  19. Wolf G., Neilson E. G. Increases in levels of collagen types I and IV messenger ribonucleic acid in murine kidneys after treatment with ciclosporin. Nephron. 1992;60(1):87–91. doi: 10.1159/000186710. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Publishing Group

RESOURCES